Abbott Targets Teva Over Latest Simcor ANDA

Law360, New York (August 16, 2011, 1:18 PM EDT) -- Abbott Laboratories on Friday continued its bid to protect the market for cholesterol drug Simcor, filing another patent infringement suit in Delaware against generic-drug maker Teva Pharmaceutical Industries Ltd.

Abbott and Abbott Respiratory LLC lodged the complaint over Teva's bid for U.S. Food and Drug Administration approval to market a generic Simcor, which contains niacin and simvastatin.

The plaintiff sued Teva in March and an additional three times in 2010 over Simcor. Friday's suit references Teva's bid for a green light to market tablets containing 500...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Abbott Laboratories et al v. Teva Pharmaceuticals USA Inc. et al


Case Number

1:11-cv-00712

Court

Delaware

Nature of Suit

Patent

Judge

Sue L. Robinson

Date Filed

August 12, 2011

Law Firms

Companies

Government Agencies

Patents